Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Executive Summary

• Quantum BioPharma announced a public whistleblower program offering cash rewards of up to USD $7 million for verifiable information that leads to a final, non‑appealable judgment or binding settlement in its stock‑manipulation lawsuit.
• The reward will be paid from the net proceeds of the ongoing litigation, which seeks > USD $700 million in damages against major financial institutions alleged to have spoofed the Company’s shares.
• The policy includes detailed eligibility criteria, confidentiality provisions, and clarifies that it does not replace or interfere with SEC or Canadian regulator whistleblower programs.

Key Details

• Reward Structure: Up to USD $7 million payable to one or multiple informants; amount determined at the Company’s discretion based on significance and impact of the information.
• Funding Source: Rewards will be funded from the net proceeds of the lawsuit once resolved; no upfront cash outlay by the Company.
• Eligibility Restrictions: Current directors, officers, employees, law‑enforcement or regulatory officials acting in official capacity, individuals who obtained information unlawfully, and those providing false/ fabricated data are excluded.
• Submission Channels: Email [email protected] or phone 1‑833‑571‑1811; written consent required before any use of the information.
• Legal Framework: Policy approved by audit committee and board; based on legal opinions from multiple law firms; does not limit participation in SEC or Canadian whistleblower programs.
• Lawsuit Overview: Plaintiff seeks > USD $700 million for alleged spoofing by CIBC World Markets, RBC Dominion Securities, and others (Jan 2020‑Aug 2024); share price fell from ~USD $460 to < USD $10.
• Contingency Representation: Law firms Christian Attar and Freedman Normand Friedland LLP are on a contingency basis; no upfront legal costs to the Company.
• Potential Expansion: Company believes manipulation may involve additional brokers/parties not yet named; whistleblower program intended to accelerate discovery of further conspirators.

Notable Quotes

“The whistleblower reward underscores our commitment to holding alleged perpetrators accountable and restoring market integrity for our shareholders.” – Zeeshan Saeed, Founder, CEO & Executive Co‑Chairman, Quantum BioPharma Ltd.